Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)
CNY 7.86
(0.51%)
CNY 7.86
(0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -227.47 Million | -175.6 Million | -162.07 Million | -114.59 Million | 44.34 Million | 165.08 Million |
| Net Income | -398.89 Million | -197 Million | -137.4 Million | -133.01 Million | 27.29 Million | 134.05 Million |
| Depreciation & Amortization | 32.44 Million | 33.99 Million | 36.79 Million | 34.87 Million | 30.36 Million | 26.75 Million |
| Deferred income taxes | 32.39 Million | -46.09 Million | -75.6 Million | -39.09 Million | -7.64 Million | 16.76 Million |
| Stock-based compensation | 3.13 Million | 9.16 Million | 26.15 Million | 5.97 Million | - | 644.65 Thousand |
| Change in working capital | 94.3 Million | -34.36 Million | -44.94 Million | 1.28 Million | 13.93 Million | 51.46 Million |
| Other non-cash items | -17.13 Million | 21.77 Million | -16.52 Million | -17.73 Million | -27.25 Million | -47.19 Million |
| Investing Cash Flow | 16.99 Million | 321.32 Million | 142.65 Million | -140.29 Million | 332.46 Million | -41.23 Million |
| Investments in PPE | -32.15 Million | -56.51 Million | -56.23 Million | -48.86 Million | -59.9 Million | -95.46 Million |
| Acquisitions | 238.27 Thousand | 10.41 Thousand | -3.39 Million | 54.53 Million | -1.57 Million | 95.46 Million |
| Investment purchases | -670 Thousand | -155.09 Million | -920 Million | -1.1 Billion | -1.88 Billion | -2.53 Billion |
| Sales/Maturities of investments | 49.57 Million | 532.91 Million | 1.11 Billion | 1 Billion | 2.27 Billion | 2.59 Billion |
| Other Investing Activities | 49.98 Million | -0.58 | 3.39 Million | -48.86 Million | 1.04 Million | -95.46 Million |
| Financing Cash Flow | 30.63 Million | 32.61 Million | -35.9 Million | 43.74 Million | -389.65 Million | -163.15 Million |
| Debt repayment | -28.79 Million | -2.62 Million | -48 Million | -2.06 Million | - | - |
| Dividends payments | -1.02 Million | - | -320.13 Thousand | -854.76 Thousand | -314.22 Million | -119.28 Million |
| Common Stock Repurchased | - | - | - | - | -71.42 Million | -27.85 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 60.45 Million | 32.61 Million | 12.41 Million | 46.66 Million | -4 Million | -43.86 Million |
| Accounts receivables | 126.59 Million | -83.74 Million | -148.11 Million | -9.18 Million | 60.37 Million | 130.75 Million |
| Accounts payables | -20.29 Million | 89.63 Million | 170.49 Million | 36.56 Million | -31.04 Million | -90.01 Million |
| Inventory | -11.99 Million | 5.85 Million | 8.28 Million | 13 Million | -7.75 Million | -6.03 Million |
| Other working capital | -1.00 | -46.09 Million | -75.6 Million | -39.09 Million | -7.64 Million | 57.49 Million |
| Cash at beginning of period | 264.98 Million | 85.01 Million | 140.57 Million | 352.61 Million | 365.2 Million | 401.19 Million |
| Cash at end of period | 85.18 Million | 264.98 Million | 85.01 Million | 140.57 Million | 352.61 Million | 365.2 Million |
| Capital Expenditure | -32.15 Million | -56.51 Million | -56.23 Million | -48.86 Million | -59.9 Million | -95.46 Million |
| Effect of forex changes on cash | 34.56 Thousand | 1.63 Million | -243.3 Thousand | -892.73 Thousand | 255.82 Thousand | 3.31 Million |
| Net cash flow / Change in cash | -179.8 Million | 179.97 Million | -55.56 Million | -212.03 Million | -12.58 Million | -35.99 Million |
| Free Cash Flow | -259.62 Million | -232.11 Million | -218.3 Million | -163.46 Million | -15.56 Million | 69.62 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.94 Million | 346.38 Thousand | -3.76 Million | -213.92 Million | -398.89 Million | -31.53 Million |
| Depreciation & Amortization | - | 7.91 Million | 7.91 Million | 7.8 Million | 32.44 Million | 7.8 Million |
| Deferred income taxes | - | - | - | -117.74 Million | 32.39 Million | - |
| Stock-based compensation | - | - | - | 3.13 Million | 3.13 Million | - |
| Change in working capital | - | -13.63 Million | - | 114.6 Million | 94.3 Million | -53.17 Million |
| Other non-cash items | 3.97 Million | 2.33 Million | -13.26 Million | 119.43 Million | -17.13 Million | 46.59 Million |
| Investing Cash Flow | -672.74 Thousand | 625.58 Thousand | -4.95 Million | 1.17 Million | 16.99 Million | 14.61 Million |
| Investments in PPE | -4.77 Million | -5.17 Million | -5.08 Million | -9.81 Million | -32.15 Million | -6.32 Million |
| Acquisitions | -58.50 | 90.35 Thousand | 72.83 Thousand | - | 238.27 Thousand | 8980.00 |
| Investment purchases | -15.75 Million | - | - | - | -670 Thousand | -8980.00 |
| Sales/Maturities of investments | 19.85 Million | 5.7 Million | 57.4 Thousand | 10.99 Million | 49.57 Million | 20.92 Million |
| Other Investing Activities | -15.75 Million | 5.79 Million | 130.23 Thousand | -1.00 | 49.98 Million | 8980.08 |
| Financing Cash Flow | 2.15 Million | -14.91 Million | -254.77 Thousand | -25.63 Million | 30.63 Million | 28.49 Million |
| Debt repayment | -14.12 Million | -14.66 Million | - | -78.79 Million | -28.79 Million | -14.12 Million |
| Dividends payments | -37.66 Thousand | -250.71 Thousand | -254.77 Thousand | -800.34 Thousand | -1.02 Million | -212.28 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 16.32 Million | -250.71 Thousand | -254.77 Thousand | 53.96 Million | 60.45 Million | 28.71 Million |
| Accounts receivables | - | -16.23 Million | - | 126.59 Million | 126.59 Million | -62.37 Million |
| Accounts payables | - | - | - | - | -20.29 Million | - |
| Inventory | - | 2.6 Million | - | -11.99 Million | -11.99 Million | 9.19 Million |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 43.49 Million | 62.98 Million | 85.18 Million | 196.55 Million | 264.98 Million | 183.8 Million |
| Cash at end of period | 42.73 Million | 43.49 Million | 62.98 Million | 85.18 Million | 85.18 Million | 196.55 Million |
| Capital Expenditure | -4.77 Million | -5.17 Million | -5.08 Million | -9.81 Million | -32.15 Million | -6.32 Million |
| Effect of forex changes on cash | 228.03 Thousand | 30.46 Thousand | 43.04 Thousand | -241.34 Thousand | 34.56 Thousand | 202.98 Thousand |
| Net cash flow / Change in cash | -758.82 Thousand | -19.49 Million | -22.19 Million | -111.37 Million | -179.8 Million | 12.75 Million |
| Free Cash Flow | -6.73 Million | -10.4 Million | -22.11 Million | -96.5 Million | -259.62 Million | -36.63 Million |
NCKAF
SSC
RSDFIN
FC
ACS
8114